Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2619788345', 'doi': 'https://doi.org/10.1111/1346-8138.13911', 'title': 'Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch', 'display_name': 'Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch', 'publication_year': 2017, 'publication_date': '2017-05-23', 'ids': {'openalex': 'https://openalex.org/W2619788345', 'doi': 'https://doi.org/10.1111/1346-8138.13911', 'mag': '2619788345', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/28543617', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5655923'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/1346-8138.13911', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13911', 'source': {'id': 'https://openalex.org/S143887118', 'display_name': 'The Journal of Dermatology', 'issn_l': '0385-2407', 'issn': ['0385-2407', '1346-8138'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13911', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067909005', 'display_name': 'Mamitaro Ohtsuki', 'orcid': 'https://orcid.org/0000-0001-7845-6698'}, 'institutions': [{'id': 'https://openalex.org/I146500386', 'display_name': 'Jichi Medical University', 'ror': 'https://ror.org/010hz0g26', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146500386']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Mamitaro Ohtsuki', 'raw_affiliation_strings': ['Jichi Medical University, Shimotsuke, Japan'], 'affiliations': [{'raw_affiliation_string': 'Jichi Medical University, Shimotsuke, Japan', 'institution_ids': ['https://openalex.org/I146500386']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082909666', 'display_name': 'Akimichi Morita', 'orcid': 'https://orcid.org/0000-0001-8372-3754'}, 'institutions': [{'id': 'https://openalex.org/I33858575', 'display_name': 'Nagoya City University', 'ror': 'https://ror.org/04wn7wc95', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I33858575']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Akimichi Morita', 'raw_affiliation_strings': ['Nagoya City University, Nagoya, Japan'], 'affiliations': [{'raw_affiliation_string': 'Nagoya City University, Nagoya, Japan', 'institution_ids': ['https://openalex.org/I33858575']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033463436', 'display_name': 'Atsuyuki Igarashi', 'orcid': 'https://orcid.org/0000-0002-5903-3187'}, 'institutions': [{'id': 'https://openalex.org/I2801547476', 'display_name': 'NTT Medical Center', 'ror': 'https://ror.org/0285prp25', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801547476']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Atsuyuki Igarashi', 'raw_affiliation_strings': ['NTT Medical Center Tokyo, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'NTT Medical Center Tokyo, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I2801547476']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080374235', 'display_name': 'Shinichi Imafuku', 'orcid': 'https://orcid.org/0000-0001-8568-4349'}, 'institutions': [{'id': 'https://openalex.org/I31784960', 'display_name': 'Fukuoka University', 'ror': 'https://ror.org/04nt8b154', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I31784960']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shinichi Imafuku', 'raw_affiliation_strings': ['Fukuoka University, Fukuoka, Japan'], 'affiliations': [{'raw_affiliation_string': 'Fukuoka University, Fukuoka, Japan', 'institution_ids': ['https://openalex.org/I31784960']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030954224', 'display_name': 'Yayoi Tada', 'orcid': 'https://orcid.org/0000-0003-3743-135X'}, 'institutions': [{'id': 'https://openalex.org/I4210097373', 'display_name': 'Teikyo University Hospital', 'ror': 'https://ror.org/00tze5d69', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210097373']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yayoi Tada', 'raw_affiliation_strings': ['Teikyo University, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Teikyo University, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210097373']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101459274', 'display_name': 'Hiroyuki Fujita', 'orcid': 'https://orcid.org/0000-0001-8744-8411'}, 'institutions': [{'id': 'https://openalex.org/I4210105804', 'display_name': 'Novartis (Japan)', 'ror': 'https://ror.org/01k1ftz35', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210105804']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroyuki Fujita', 'raw_affiliation_strings': ['Novartis Pharma KK, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Novartis Pharma KK, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210105804']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015916303', 'display_name': 'Ayako Fujishige', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105804', 'display_name': 'Novartis (Japan)', 'ror': 'https://ror.org/01k1ftz35', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210105804']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ayako Fujishige', 'raw_affiliation_strings': ['Novartis Pharma KK, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Novartis Pharma KK, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210105804']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089584701', 'display_name': 'M. Yamaguchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105804', 'display_name': 'Novartis (Japan)', 'ror': 'https://ror.org/01k1ftz35', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210105804']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masako Yamaguchi', 'raw_affiliation_strings': ['Novartis Pharma KK, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Novartis Pharma KK, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210105804']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036290528', 'display_name': 'Rie Teshima', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105804', 'display_name': 'Novartis (Japan)', 'ror': 'https://ror.org/01k1ftz35', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210105804']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Rie Teshima', 'raw_affiliation_strings': ['Novartis Pharma KK, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Novartis Pharma KK, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210105804']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066470942', 'display_name': 'Yumiko Tani', 'orcid': 'https://orcid.org/0000-0002-0271-2891'}, 'institutions': [{'id': 'https://openalex.org/I4210105804', 'display_name': 'Novartis (Japan)', 'ror': 'https://ror.org/01k1ftz35', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210105804']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yumiko Tani', 'raw_affiliation_strings': ['Novartis Pharma KK, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'Novartis Pharma KK, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I4210105804']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5068242406', 'display_name': 'Hidemi Nakagawa', 'orcid': 'https://orcid.org/0000-0002-8272-4488'}, 'institutions': [{'id': 'https://openalex.org/I115498069', 'display_name': 'Jikei University School of Medicine', 'ror': 'https://ror.org/039ygjf22', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I115498069']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hidemi Nakagawa', 'raw_affiliation_strings': ['The Jikei University School of Medicine, Tokyo, Japan'], 'affiliations': [{'raw_affiliation_string': 'The Jikei University School of Medicine, Tokyo, Japan', 'institution_ids': ['https://openalex.org/I115498069']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 7, 'corresponding_author_ids': ['https://openalex.org/A5067909005'], 'corresponding_institution_ids': ['https://openalex.org/I146500386'], 'apc_list': {'value': 3630, 'currency': 'USD', 'value_usd': 3630, 'provenance': 'doaj'}, 'apc_paid': {'value': 3630, 'currency': 'USD', 'value_usd': 3630, 'provenance': 'doaj'}, 'fwci': 1.116, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 13, 'citation_normalized_percentile': {'value': 0.734686, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 88, 'max': 89}, 'biblio': {'volume': '44', 'issue': '10', 'first_page': '1105', 'last_page': '1111'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10469', 'display_name': 'Reciprocal Development of TH17 and Treg Cells', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10469', 'display_name': 'Reciprocal Development of TH17 and Treg Cells', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11730', 'display_name': 'Pathogenesis and Treatment of Pemphigoid Diseases', 'score': 0.9943, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10837', 'display_name': 'Atopic Dermatitis and Skin Microbiome', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.66080517}, {'id': 'https://openalex.org/keywords/safety-profile', 'display_name': 'Safety profile', 'score': 0.51513517}, {'id': 'https://openalex.org/keywords/psoriasis', 'display_name': 'Psoriasis', 'score': 0.485918}], 'concepts': [{'id': 'https://openalex.org/C2779786854', 'wikidata': 'https://www.wikidata.org/wiki/Q7444755', 'display_name': 'Secukinumab', 'level': 4, 'score': 0.992342}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9031635}, {'id': 'https://openalex.org/C2780564577', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Psoriasis', 'level': 2, 'score': 0.8016027}, {'id': 'https://openalex.org/C2777011040', 'wikidata': 'https://www.wikidata.org/wiki/Q390643', 'display_name': 'Psoriasis Area and Severity Index', 'level': 3, 'score': 0.7684625}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.66080517}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.6468302}, {'id': 'https://openalex.org/C3018359032', 'wikidata': 'https://www.wikidata.org/wiki/Q1550789', 'display_name': 'Safety profile', 'level': 3, 'score': 0.51513517}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.3926404}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3876145}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.35315433}, {'id': 'https://openalex.org/C2776260265', 'wikidata': 'https://www.wikidata.org/wiki/Q511097', 'display_name': 'Psoriatic arthritis', 'level': 3, 'score': 0.07621321}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016572', 'descriptor_name': 'Cyclosporine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D003879', 'descriptor_name': 'Dermatologic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D057915', 'descriptor_name': 'Drug Substitution', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D020381', 'descriptor_name': 'Interleukin-17', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001691', 'descriptor_name': 'Biological Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001691', 'descriptor_name': 'Biological Therapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D001691', 'descriptor_name': 'Biological Therapy', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D016572', 'descriptor_name': 'Cyclosporine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003879', 'descriptor_name': 'Dermatologic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D057915', 'descriptor_name': 'Drug Substitution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D057915', 'descriptor_name': 'Drug Substitution', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020381', 'descriptor_name': 'Interleukin-17', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007564', 'descriptor_name': 'Japan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011446', 'descriptor_name': 'Prospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011565', 'descriptor_name': 'Psoriasis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012720', 'descriptor_name': 'Severity of Illness Index', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/1346-8138.13911', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13911', 'source': {'id': 'https://openalex.org/S143887118', 'display_name': 'The Journal of Dermatology', 'issn_l': '0385-2407', 'issn': ['0385-2407', '1346-8138'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5655923', 'pdf_url': 'https://europepmc.org/articles/pmc5655923?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655923', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/28543617', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/1346-8138.13911', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1346-8138.13911', 'source': {'id': 'https://openalex.org/S143887118', 'display_name': 'The Journal of Dermatology', 'issn_l': '0385-2407', 'issn': ['0385-2407', '1346-8138'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.83, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [{'funder': 'https://openalex.org/F4320332736', 'funder_display_name': 'Novartis Pharma', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 26, 'referenced_works': ['https://openalex.org/W1548178271', 'https://openalex.org/W1552422862', 'https://openalex.org/W1573665101', 'https://openalex.org/W1589693489', 'https://openalex.org/W1873491332', 'https://openalex.org/W1935617463', 'https://openalex.org/W1973354423', 'https://openalex.org/W2008635283', 'https://openalex.org/W2016898503', 'https://openalex.org/W2027145044', 'https://openalex.org/W2064645845', 'https://openalex.org/W2069350424', 'https://openalex.org/W2080237150', 'https://openalex.org/W2083502021', 'https://openalex.org/W2087777607', 'https://openalex.org/W2103524303', 'https://openalex.org/W2110441300', 'https://openalex.org/W2112128505', 'https://openalex.org/W2113110474', 'https://openalex.org/W2151209321', 'https://openalex.org/W2151280501', 'https://openalex.org/W2278932593', 'https://openalex.org/W2279719049', 'https://openalex.org/W2359919307', 'https://openalex.org/W2477623319', 'https://openalex.org/W2516525712'], 'related_works': ['https://openalex.org/W4303857398', 'https://openalex.org/W3176363967', 'https://openalex.org/W3044482886', 'https://openalex.org/W3022724713', 'https://openalex.org/W2781166685', 'https://openalex.org/W2621467536', 'https://openalex.org/W2619788345', 'https://openalex.org/W2588369178', 'https://openalex.org/W2343185506', 'https://openalex.org/W2032633556'], 'abstract_inverted_index': {'There': [0], 'are': [1], 'limited': [2], 'data': [3, 201], 'on': [4], 'the': [5, 24, 30, 120, 126, 188, 212], 'safety': [6, 33, 196, 207], 'and': [7, 32, 61, 73, 80, 93, 113, 159, 178, 227], 'efficacy': [8, 31, 103], 'of': [9, 23, 34, 104, 125, 140, 154, 163, 176, 211], 'switching': [10, 41], 'to': [11, 28, 64, 110, 233], 'secukinumab': [12, 35, 67, 105, 217], 'from': [13, 42, 88, 231], 'cyclosporine': [14], 'A': [15], '(CyA)': [16], 'in': [17, 44, 90, 171, 187, 220], 'patients': [18, 45, 57, 141, 221], 'with': [19, 46, 58, 148, 150, 199, 202, 222], 'psoriasis.': [20, 48], 'The': [21, 82, 102, 122, 209], 'purpose': [22], 'present': [25, 213], 'study': [26, 190, 214], 'was': [27, 85, 107, 133], 'assess': [29], 'for': [36], '16': [37, 132], 'weeks': [38, 74], 'after': [39], 'direct': [40, 229], 'CyA': [43, 65, 232], 'moderate-to-severe': [47, 59], 'In': [49], 'this': [50], 'multicenter,': [51], 'open-label,': [52], 'phase': [53], 'IV': [54], 'study,': [55], '34': [56], 'psoriasis': [60, 223], 'inadequate': [62], 'response': [63, 129, 153, 162], 'received': [66], '300': [68], 'mg': [69], 's.c.': [70], 'at': [71, 99, 130, 156, 165], 'baseline': [72, 89], '1,': [75], '2,': [76], '3,': [77], '4,': [78], '8': [79], '12.': [81], 'primary': [83, 123], 'end-point': [84, 124], '≥75%': [86], 'improvement': [87], 'Psoriasis': [91], 'Area': [92], 'Severity': [94], 'Index': [95], 'score': [96], '(PASI': [97], '75)': [98], 'week': [100, 111, 131, 157, 166], '16.': [101], 'treatment': [106], 'evaluated': [108], 'up': [109], '16,': [112], 'adverse': [114], 'events': [115], '(AE)': [116], 'were': [117, 146, 169, 180], 'monitored': [118], 'during': [119], 'study.': [121], 'PASI': [127, 151, 160], '75': [128, 161], 'achieved': [134], 'by': [135], '82.4%': [136], '(n': [137, 173], '=': [138, 174], '28)': [139], 'receiving': [142], 'secukinumab.': [143], 'Early': [144], 'improvements': [145], 'observed': [147, 170], 'secukinumab,': [149], '50': [152], '41.2%': [155], '2': [158], '44.1%': [164], '4.': [167], 'AE': [168, 183], '70.6%': [172], '24)': [175], 'patients,': [177], 'there': [179], 'no': [181, 203], 'serious': [182], 'or': [184, 205], 'deaths': [185], 'reported': [186], 'entire': [189], 'period.': [191], 'Secukinumab': [192], 'showed': [193], 'a': [194, 225], 'favorable': [195], 'profile': [197], 'consistent': [198], 'previous': [200], 'new': [204], 'unexpected': [206], 'signals.': [208], 'results': [210], 'show': [215], 'that': [216], 'is': [218], 'effective': [219], 'enabling': [224], 'smooth': [226], 'safe': [228], 'switch': [230], 'biological': [234], 'therapy.': [235]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2619788345', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 2}], 'updated_date': '2024-09-09T20:41:47.330679', 'created_date': '2017-06-05'}